Approval · Notice of Compliance 38254 · 2026
JAMP ACYCLOVIR: Notice of Compliance 38254
Issued September 9, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 38254
- Date
- September 9, 2026
- Company
- JAMP Pharma CorporationBoucherville, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Canadian reference product
- APO-ACYCLOVIR (Apotex Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| JAMP ACYCLOVIR | 02571315 | Approved |
| JAMP ACYCLOVIR | 02571323 | Approved |